Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Preventing radiation retinopathy with hyperfractionation.

Alan T Monroe1, Niranjan Bhandare, Christopher G Morris

  • 1Department of Radiation Oncology, University of Florida College of Medicine, Health Science Center, 2000 SW Archer Road, Gainesville, FL 32608, USA.

International Journal of Radiation Oncology, Biology, Physics
|February 15, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ten-year outcomes for image-guided moderately hypofractionated proton therapy for prostate cancer.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Long-Term Outcomes of Consolidative Proton Therapy for Pediatric Classical Hodgkin Lymphoma.

International journal of particle therapy·2026
Same author

A Systematic Study on Local Failure Events Post Chemoradiation Therapy for Cervical Cancer: Understanding the Impact of Baseline Lateral Anatomic Compartment Involvement.

International journal of radiation oncology, biology, physics·2025
Same author

Pattern of recurrence with 1.0 cm CTV in brain glioblastoma treated with radiotherapy.

Journal of neuro-oncology·2025
Same author

Association Between Brain Substructure Dose and Scholastic Performance in Pediatric Brain Tumor Survivors Who Received Radiation Therapy.

International journal of radiation oncology, biology, physics·2025
Same author

Independent Review Organization and Proton Therapy: Multistate Analysis and Legal Procedural Strategies.

International journal of particle therapy·2025
Same journal

Single Percussive Ventilation Breath-hold Imaging and Delivery in Lung Tumor Stereotactic Ablative Radiation Therapy: Initial Observations From a Prospective Clinical Trial.

International journal of radiation oncology, biology, physics·2026
Same journal

Proton beam therapy in nonmetastatic rhabdomyosarcoma: Outcome, prognostic factors and the effect of timing of radiation therapy.

International journal of radiation oncology, biology, physics·2026
Same journal

Hypofractionated Proton Reirradiation for Recurrent Glioblastoma: Clinical and Dosimetric Outcomes from a Large Single Institution Series.

International journal of radiation oncology, biology, physics·2026
Same journal

Gastrointestinal Motility-Induced Interplay in Pancreas Proton Therapy: Motion Simulation and Dosimetric Impact.

International journal of radiation oncology, biology, physics·2026
Same journal

Intra-fractional Voxel-wise Anatomical Motion Tracking Guided by Multimodal Respiratory Surrogates in Radiotherapy: Framework Development and Multi-Center Validation.

International journal of radiation oncology, biology, physics·2026
Same journal

A Gaussian-based planning approach for robust dose-escalated stereotactic body proton therapy.

International journal of radiation oncology, biology, physics·2026
See all related articles

Radiation retinopathy risk is reduced with hyperfractionated radiotherapy, especially at higher retinal doses. This head-and-neck cancer treatment strategy lowers the incidence of vision loss.

Area of Science:

  • Ophthalmology
  • Radiation Oncology
  • Oncology

Background:

  • Radiation retinopathy is a significant complication of radiotherapy for head-and-neck cancers.
  • Understanding risk factors is crucial for mitigating vision loss in these patients.

Purpose of the Study:

  • To identify factors associated with radiation retinopathy development in head-and-neck cancer patients.
  • To evaluate the efficacy of hyperfractionated radiation therapy in reducing retinopathy risk.

Main Methods:

  • Retrospective analysis of 186 head-and-neck cancer patients treated with curative radiotherapy.
  • Retinal doses were calculated, with a median of 56.85 Gy.
  • Patients were followed for a median of 7.6 years.

Main Results:

Related Experiment Videos

  • The 5- and 10-year actuarial incidence of radiation retinopathy was 20%.
  • Higher retinal doses (≥60 Gy) and longer treatment times increased risk.
  • Hyperfractionated radiotherapy (twice-daily) significantly reduced retinopathy incidence (13% vs. 37%) when retinal doses exceeded 50 Gy.

Conclusions:

  • Retinal dose and fractionation schedule are key predictors of radiation retinopathy.
  • Hyperfractionated radiotherapy offers a significant protective effect against radiation retinopathy, particularly at high doses.
  • This approach can help preserve vision in head-and-neck cancer patients receiving radiotherapy.